KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Inventory (2016 - 2026)

Idexx Laboratories has reported Inventory over the past 17 years, most recently at $377.8 million for Q4 2025.

  • For Q4 2025, Inventory fell 1.08% year-over-year to $377.8 million; the TTM value through Dec 2025 reached $377.8 million, down 1.08%, while the annual FY2025 figure was $377.8 million, 1.08% down from the prior year.
  • Inventory for Q4 2025 was $377.8 million at Idexx Laboratories, down from $391.6 million in the prior quarter.
  • Over five years, Inventory peaked at $396.0 million in Q1 2025 and troughed at $225.6 million in Q1 2021.
  • A 5-year average of $350.6 million and a median of $380.1 million in 2023 define the central range for Inventory.
  • Biggest five-year swings in Inventory: soared 37.77% in 2022 and later fell 3.84% in 2024.
  • Year by year, Inventory stood at $269.0 million in 2021, then surged by 36.72% to $367.8 million in 2022, then grew by 3.39% to $380.3 million in 2023, then rose by 0.42% to $381.9 million in 2024, then fell by 1.08% to $377.8 million in 2025.
  • Business Quant data shows Inventory for IDXX at $377.8 million in Q4 2025, $391.6 million in Q3 2025, and $392.6 million in Q2 2025.